Literature DB >> 16750212

Evaluation and comparison of alternatives to Protein A chromatography Mimetic and hydrophobic charge induction chromatographic stationary phases.

Sanchayita Ghose1, Brian Hubbard, Steven M Cramer.   

Abstract

In this paper Protein A mimetic and hydrophobic charge induction chromatographic (HCIC) stationary phases are characterized in terms of their protein adsorption characteristics and their selectivity is compared with Protein A chromatography using a set of Chinese hamster ovary-derived monoclonal antibodies and Fc-fusion proteins. Linear retention experiments were employed to compare the selectivities of these resins for both non-IgG model proteins as well as antibodies and the fusion proteins. While none of the non-IgG model proteins were observed to bind to the Protein A resin, most of them did in fact bind to the alternative resins. In addition, while the elution pH was similar for the model proteins and antibodies on the HCIC resin, the mimetic resins did exhibit higher binding for the antibodies under these linear pH gradient conditions. A mixed mode preparative isotherm model previously developed for HCIC was shown to accurately describe the adsorption behavior of the mimetic materials as well. Host cell protein clearance profiles were also investigated under preparative conditions using complex biological feeds and the results indicated that while some selectivity was observed for both the HCIC and the mimetic materials, the purification factors were in general significantly less than those obtained with Protein A. It is important to note, however, that the selectivity of the mimetic and HCIC materials was also observed to be antibody specific indicating that further optimization may well result in increased selectivities for these materials.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750212     DOI: 10.1016/j.chroma.2006.04.083

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  7 in total

1.  Minibodies and Multimodal Chromatography Methods: A Convergence of Challenge and Opportunity.

Authors:  Pete Gagnon; Chia-Wei Cheung; Eric J Lepin; Anna M Wu; Mark A Sherman; Andrew A Raubitschek; Paul J Yazaki
Journal:  Bioprocess Int       Date:  2010-02

Review 2.  Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics.

Authors:  Timo Rath; Kristi Baker; Jennifer A Dumont; Robert T Peters; Haiyan Jiang; Shuo-Wang Qiao; Wayne I Lencer; Glenn F Pierce; Richard S Blumberg
Journal:  Crit Rev Biotechnol       Date:  2013-10-24       Impact factor: 8.429

3.  Thymosin Alpha1-Fc Modulates the Immune System and Down-regulates the Progression of Melanoma and Breast Cancer with a Prolonged Half-life.

Authors:  Fanwen Wang; Tingting Yu; Heng Zheng; Xingzhen Lao
Journal:  Sci Rep       Date:  2018-08-17       Impact factor: 4.379

4.  Pilot-scale process for magnetic bead purification of antibodies directly from non-clarified CHO cell culture.

Authors:  Nils A Brechmann; Per-Olov Eriksson; Kristofer Eriksson; Sven Oscarsson; Jos Buijs; Atefeh Shokri; Göran Hjälm; Véronique Chotteau
Journal:  Biotechnol Prog       Date:  2019-01-30

5.  Regulation of T Cell Activities in Rheumatoid Arthritis by the Novel Fusion Protein IgD-Fc-Ig.

Authors:  Jing Zhang; Xiaoxi Hu; Xiaojie Dong; Wensheng Chen; Lingling Zhang; Yan Chang; Yujing Wu; Wei Wei
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

Review 6.  CDMOs Play a Critical Role in the Biopharmaceutical Ecosystem.

Authors:  Hideyuki Kurata; Tetsuya Ishino; Yasuhiro Ohshima; Masafumi Yohda
Journal:  Front Bioeng Biotechnol       Date:  2022-03-21

Review 7.  Sophisticated Cloning, Fermentation, and Purification Technologies for an Enhanced Therapeutic Protein Production: A Review.

Authors:  Sanjeev K Gupta; Pratyoosh Shukla
Journal:  Front Pharmacol       Date:  2017-07-04       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.